These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1588553)

  • 1. 1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors.
    Martin SF; Austin RE; Oalmann CJ; Baker WR; Condon SL; deLara E; Rosenberg SH; Spina KP; Stein HH; Cohen J
    J Med Chem; 1992 May; 35(10):1710-21. PubMed ID: 1588553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
    Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
    J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors.
    Martin SF; Dorsey GO; Gane T; Hillier MC; Kessler H; Baur M; Mathä B; Erickson JW; Bhat TN; Munshi S; Gulnik SV; Topol IA
    J Med Chem; 1998 May; 41(10):1581-97. PubMed ID: 9572884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopropane-derived peptidomimetics. design, synthesis, and evaluation of novel Ras farnesyltransferase inhibitors.
    Hillier MC; Davidson JP; Martin SF
    J Org Chem; 2001 Mar; 66(5):1657-71. PubMed ID: 11262110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclopropane-derived peptidomimetics. Design, synthesis, and evaluation of novel enkephalin analogues.
    Martin SF; Dwyer MP; Hartmann B; Knight KS
    J Org Chem; 2000 Mar; 65(5):1305-18. PubMed ID: 10814090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.
    Davidson JP; Lubman O; Rose T; Waksman G; Martin SF
    J Am Chem Soc; 2002 Jan; 124(2):205-15. PubMed ID: 11782172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Conformationally Restricted β-Strand HIV Protease Inhibitor.
    Hillier MC; Martin SF
    Methods Mol Med; 1999; 23():397-406. PubMed ID: 21380909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and properties of cyclopropane-derived peptidomimetics.
    Reichelt A; Martin SF
    Acc Chem Res; 2006 Jul; 39(7):433-42. PubMed ID: 16846207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
    Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
    J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of versatile cis- and trans-dicarbon-substituted chiral cyclopropane units: synthesis of (1S,2R)- and (1R,2R)-2-aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and their enantiomers as conformationally restricted analogues of histamine.
    Kazuta Y; Matsuda A; Shuto S
    J Org Chem; 2002 Mar; 67(5):1669-77. PubMed ID: 11871901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramolecular Pauson-Khand reactions of methylenecyclopropane and bicyclopropylidene derivatives as an approach to spiro(cyclopropanebicyclo[n.3.0]alkenones).
    de Meijere A; Becker H; Stolle A; Kozhushkov SI; Bes MT; Salaün J; Noltemeyer M
    Chemistry; 2005 Apr; 11(8):2471-82. PubMed ID: 15685585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
    J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of cyclopropane-containing leu-enkephalin analogs.
    Dwyer MP; Martin SF
    Methods Mol Med; 1999; 23():407-16. PubMed ID: 21380910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1,1,2-trisubstituted cyclopropane nucleosides in enantiomerically pure forms.
    Fushihara D; Fukuda H; Abe H; Shuto S
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(12):921-941. PubMed ID: 31187692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
    Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
    J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolinone-based peptidomimetics. "Let the enzyme or receptor be the judge".
    Smith AB; Charnley AK; Hirschmann R
    Acc Chem Res; 2011 Mar; 44(3):180-93. PubMed ID: 21175156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate.
    Molinaro C; Shultz S; Roy A; Lau S; Trinh T; Angelaud R; O'Shea PD; Abele S; Cameron M; Corley E; Funel JA; Steinhuebel D; Weisel M; Krska S
    J Org Chem; 2011 Feb; 76(4):1062-71. PubMed ID: 21250716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient approaches to the stereoselective synthesis of cyclopropyl alcohols.
    Kim HY; Walsh PJ
    Acc Chem Res; 2012 Sep; 45(9):1533-47. PubMed ID: 22725974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors.
    Plummer MS; Shahripour A; Kaltenbronn JS; Lunney EA; Steinbaugh BA; Hamby JM; Hamilton HW; Sawyer TK; Humblet C; Doherty AM
    J Med Chem; 1995 Jul; 38(15):2893-905. PubMed ID: 7636850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational restriction approach to BACE1 inhibitors II: SAR study of the isocytosine derivatives fixed with a cis-cyclopropane ring.
    Yonezawa S; Yamakawa H; Muto C; Hosono M; Yamamoto T; Hattori K; Sakagami M; Togame H; Tanaka Y; Nakano T; Takemoto H; Arisawa M; Shuto S
    Bioorg Med Chem Lett; 2013 May; 23(10):2912-5. PubMed ID: 23562056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.